When it comes to rare disease, clear genetic insights can help providers deliver personalized care to their patients. Join us at #ASHG25 for our education session where we will share how, through our partnership with Alexion, we have combined variant knowledge datasets in an effort to reduce variants of uncertain significance and ultimately expand diagnostic and therapeutic options for patients. Visit us at booth 834
Invitae
Biotechnology Research
San Francisco, CA 147,526 followers
As a Labcorp company, we’re bringing comprehensive genetic information into mainstream medicine to improve healthcare.
About us
Invitae, now part of Labcorp, is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We’re working to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of our mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Within each of us lies information coded in our DNA that can transform our health. Unlocking that potential requires highly specialized, multidisciplinary collaboration. Our world-class genetics experts drive the development of a highly complex system of tools and processes, including robotics, artificial intelligence, machine learning, and software engineering. All of this comes together to provide patients with accurate, reliable results that can help guide decisions across the healthcare journey and potentially change lives today and for the next generation. Our teammates are grounded in a universal sense of urgency and ownership. We believe in the team above the individual and celebrate freedom with accountability. Employees are encouraged to speak up, try new things and make decisions that push us forward. We provide all Invitaens with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. At Invitae, we're putting patients' genetic insights where they belong—at the center of healthcare. And we're doing it together, with you. Join us.
- Website
-
http://www.invitae.com/
External link for Invitae
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- San Francisco, CA
- Type
- Public Company
- Specialties
- genomics, biotechnology, healthcare, oncology, cancer, cardiology, rare genetic disease, neurology, hematology, pediatric genetics, and genetic testing
Locations
-
Primary
Get directions
1400 16th Street
San Francisco, CA 94103, US
-
Get directions
1400 16th St
San Francisco, CA 94103, US
Employees at Invitae
Updates
-
We’re proud to expand our partnership with BioMarin Pharmaceutical Inc. by helping advance early diagnosis for children with unexplained seizures. The Behind the Seizure® sponsored testing program is back, providing no-cost genetic testing for children under 10 who experienced seizure onset between 2 and 5 years of age. With nearly 50% of epilepsies having a genetic basis, early testing can reveal answers that guide care. Learn more https://bit.ly/48QkEMX #BehindtheSeizure #GeneticTesting #PediatricEpilepsy #RareDisease #EarlyDiagnosis
-
-
APDS is a rare, progressive immunodeficiency that often goes undiagnosed for years, delaying critical care. This awareness day serves as a reminder of the importance of early diagnosis and the need to continue advancing access to genetic testing for patients with immune dysregulation. Read more https://bit.ly/4nwQFOE #APDS #Immunology #RareDisease #PrecisionMedicine #genetictesting
-
-
The PROCLAIM trial offers a rare, insightful look into patient-reported outcomes following universal germline genetic testing for prostate cancer. Most patients reported no added stress from testing, and those with positive results largely took action based on their genetic results. The study uncovered certain gaps in comprehension and communication that could impact care. Read the full article to explore the findings and discover how they could shape your approach to care: https://lnkd.in/g8zSV24B
-
-
Inborn errors of immunity (IEIs) are often underdiagnosed due to their clinical complexity. Among them, Activated PI3K Delta Syndrome (APDS) is a rare but actionable condition—yet many patients face years of diagnostic delay. This new publication, developed in collaboration with Pharming and Invitae (now a part of Labcorp), highlights the clinical utility of broad genetic testing through the navigateAPDS Sponsored Testing Program. It reinforces the value of early molecular diagnosis in improving outcomes and enabling precision therapies for patients with immune dysregulation. Read the full publication here http://spr.ly/6047ARTM9 #GeneticTesting #Immunology #APDS #PrecisionMedicine #Invitae #RareDisease
-
-
Join us for the third installment of our series on the combined importance of machine learning and human expertise in clinical laboratories. Our experts will dive into the transformative power of MAVEs in clinical variant classification and explore how MAVEs can help reclassify variants, reduce variants of uncertain significance (VUS) and enhance clinical actionability. Don’t miss it—register today http://spr.ly/6048ARr8r
-
-
Invitae reposted this
Scarlett’s family history of Lynch syndrome meant an increased risk for certain cancers. It also made Scarlett hesitant to seek genetic testing for the condition. Find out how Scarlett found the courage to get tested and how their experience encouraged them to help others. Read Scarlett’s story here: http://spr.ly/6042fFprC
-
-
Join us for a continuation of our series on the importance of human expertise in clinical laboratories. Subject matter experts will explore how scientists guide the development, validation and responsible use of automation and AI tools to enhance the accuracy and scale of clinical variant classification. Register today http://spr.ly/6047fSJsb
-
Invitae reposted this
When Noah began having cardiac arrests at 18 months old, his doctors couldn’t figure out why. A genetic test helped reveal the answer and gave his parents more certainty about how to protect him from future heart trouble. Read Noah’s story here: http://spr.ly/6043fcElh
-
-
Invitae reposted this
Every child’s diagnostic journey is unique, and our goal is to help more of them get the diagnoses they need. Our trusted genetic testing and counseling are aligned with society recommendations and can support families navigating developmental delays and intellectual disabilities, helping shorten the path to answers and improve outcomes. Learn more at http://spr.ly/6041fkL1D #Genetics
-